Counterfeit Medicines and Fight against Counterfeit Medicines.

Slides:



Advertisements
Similar presentations
الرابطة الدولية لمكافحة المواد الطبيّة المزورة a WHO initiative to combat counterfeit medical products Dr V. Reggi - World Health Organization.
Advertisements

Quality Assurance Processes for TB Drugs. GDF Quality Assurance Processes.
IMPACT Regional Conference on Combacting Counterfeit Medical Products 9-10 November 2009 Kempton Park – South Africa Mozambique Experience.
LEGISLATION, REGISTRATION AND CONTROL PROCEDURES FOR VETERINARY MEDICINAL PRODUCTS IN SOUTH AFRICA Dr R D Sykes DAKAR Senegal 2008.
Prior Safety Management System of Imported Food
Medsafe – GMP update / release for supply / communicating quality issues Derek Fitzgerald Manager, Compliance Management 11 July 2013 RACI Pharmaceutical.
Brand Protection: In the face of mounting counterfeiting, diversion & other infringements Jim Mentone | Director, Consumer Global Brand Protection.
PSM India Bejon Misra, Founder Director.
TRADE. Bringing Practical Tools To Trade Development and Integration In Europe, the Caucasus and Central Asia.
MeTa, Solwezi 27 August,2013.  A branded- name drug product is originally discovered and developed by a pharmaceutical company.  Branded-name drugs.
1 Promoting Safe Medicine With Track and Trace Systems SRC Technologies, Inc.
BRC Global Standards. Trust in Quality. Colombia Moving Forward BRC Global Standard for Food Safety John Kukoly.
Counterfeit Drugs Megan Penecale.
1. RCC Industry Panel – Consumer Products Presentation to RCC Stakeholder Dialogue Session June 20, 2013 Darren Praznik President & CEO, Canadian Cosmetic,
November 2011 Ministry of Commerce and Industry AGRIBUSINESS ACTION PLAN.
Huzairy Hassan School of Bioprocess Engineering UniMAP.
Analysis of the Pharmaceutical Supply Chain in Jordan Simon Conesa 1, Prashant Yadav 1, Rania Bader 2 (2009) 1 MIT-Zaragoza International Logistics Program,
Regulatory Overview.
Quality In Investigational Drugs Presented by: Larry Parker, BSMT (ASCP), MHSA, ASQ CQA American Society for Quality Central Arkansas Section 1407.
BCI Supply Chain Workshop Thursday 13th October, Belfast
Pharmaceutical Manufacturers Association PMA Status of National Production Capacity of Generic Medicines – Private Sector Perspective Emmanuel Mujuru,
Ways and means of improving the effectiveness of the system of state regulation of trade in medicines R.U.Khabriev Head of the Federal Inspectorate for.
THE HIGHLIGHTS OF DRUG REGULATION IN KENYA. Presentation by: Dr. Joseph K. Yano B.Pharm (Nbi) L.L.B (Moi) Legal Officer Pharmacy and Poisons Board Ministry.
Logistic services. 1. Company overview  MSL Logistical Services was founded in 2009 as a response to pharmaceutical market requirements.  Certifications.
Hans M Vemer Quality of family planning products the view of the pharma industry.
Cavendish Scott, Inc. 1 Regulatory and Statutory Compliance: It’s Everybody’s Business! Diana Lough Cavendish Scott, Inc.
1 Stop Stock-outs! Access to Medicines for All! anti-counterfeiting initiatives and other access barriers Christa Cepuch OSI AEM Initiative – CS Role and.
Saving Lives, Saving Money Lilia Bounab – Healthcare Sales Manager EMEA Ar ł amów hotel, 14-16th June 2015.
The market surveillance use for deal against the counterfeited products (Problems and solutions) UNECE International Seminar on Product Safety and Counterfeiting.
Lecture Topic 4: Good Manufacturing Practices (GMPs)
Important informations
ACCESS TO MEDICINES - POLICY AND ISSUES
Zambia’s Porous Borders & the Influx of Medicines.
2004: 39.4 (35.9 – 44.3) million Western & Central Europe [ – ] North Africa & Middle East [ – 1.5 million] Sub-Saharan.
Pharmacy Practices Provided by Dispensing Doctors in Zimbabwe Hansen EH and Trap B Danish University of Pharmaceutical Sciences, Copenhagen, Denmark &
30/02/2008 Dept. of Pharmaceutics 1 Salient Features of Quality Assurance Dr. Basavaraj K. Nanjwade M.Pharm., Ph.D Associate Professor Department of Pharmaceutics.
Quality & Safety of Generic Drugs in the World Market World Bank Conference “Good Intentions – Bad Drugs” March 10, 2005 Washington, D.C. Christine Simmon.
Framework for combating Importation, Supply and Use of Counterfeit/substandard terminals in EACO member states Presenter Mwende Njiraini Communications.
The evolution and role of Logistics in Business Chapter 1.
The Second Annual Medical Device Regulatory, Reimbursement and Compliance Congress Presented by J. Glenn George Thursday, March 29, 2007 Day II – Track.
By: Drew Perry. Counterfeit pharmaceutical drugs are fraudulently produced or mislabeled medicines purchased by consumers who believe them to be legitimate.
as a partner AussieBlends® and Frosty Boy Australia® engaged a partnership to craft high quality powdered bases for the USA and Latin America palate.
1.What are the drug quality issues that this country is facing?
Workshop on Accreditation of Bodies Certifying Medical Devices Kiev, November 2014.
1 CHALLENGES IN REGULATING QUALITY AND RATIONAL USE OF ANTIBIOTICS ALLIANCE FOR THE PRUDENT USE OF ANTIBIOTICS: INAGURAL MEETING COURTYARD.
Top 9 benefits of generic pharmacy Published by :
Prepared by: Imon Rahman Lecturer Department of Pharmacy BRAC University.
The Transposition of the Falsified Medicines Directive – the UK story
Serbia Chapter 28 – Consumer and Health Protection Medicinal Products FALSIFIED MEDICINAL PRODUCTS Mira Kontic senior advisor for legislation Ministry.
MeTA Phase I: Where are we? MeTA18/06/ MeTA2 The MeTA Phase I Proposal Purpose To pilot a new multi-stakeholder approach towards increasing transparency.
Securing the Fresh Produce Supply Chain. Introduction The Fresh Produce Association of the Americas was founded in 1944 FPAA works to ensure market access.
INTRODUCTION A national drug policy is a document which covers all the areas and issues related to drugs. This document outlines all aspects of drugs.
Author: Nurul Azyyati Sabri
ROLES AND RESPONSIBILITIES OF TFDA ON ADDO PROGRAM
ACCESS TO QUALITY MEDICINES IN THE REGION-COUNTERFEITING PROBLEMS
GOOD MANUFACTURING PRACTICE FOR BIOPROCESS ENGINEERING (ERT 425)
Presentation on Good Manufacturing Practice
HHM 5014 NUTRACEUTICAL FORMULATION TECHNOLOGY
Quality Assurance and Quality Control in Generics
Lesson 7: BRITE Seminar: GMP II
Good Manufacturing Practices GMP ممارسات التصنيع الجيد
Present By:- Company Name: Global Market Forecastes Tel: / Web:
Beyond Compliance: Using Private Certification To Exceed Expectations Robert Prevendar, Global Managing Director, NSF International, Supply Chain Food.
Regulation of Medical Products & Patient Safety- A Narrative Review
Counterfeiting and Intellectual property theft in Medicines World Bank Symposium March 10, 2005 Washington DC Frederick Razzaghi Director of Technical.
Compounded Drugs and Lack of Premarket FDA-Approval
THE HIGHLIGHTS OF DRUG REGULATION IN KENYA
WORKSHOP ON OPTIMAL PROCUREMENT OF AFFORDABLE AND QUALITY ASSURED LIFE-SAVING COMMODITIES FOR MATERNAL HEALTH KAMPALA, UGANDA - REGULATORY STATUS AND QUALITY.
MarketsandMarkets Presents Agricultural Biologicals Testing Market worth 1.12 Billion USD by 2021.
Storage and distribution
Presentation transcript:

Counterfeit Medicines and Fight against Counterfeit Medicines

Good Quality Medicines Effective Safe

Regulatory GXP GMPGood Manufacturing Practice GLP GSPHigh Quality Products GDP

Counterfeit Fake and false Fake currencies Fake credit cards Fake medicines (the Pills that kill)

Imitating the most sophisticated packaging and the dosage shape of the brand

Crime Medicines Easy made for you Cheap medicines with high margines High risk medicines Easily entering the supply chain

Crime Medicines People can die of the counterfeit medicines

Bogus Medicines WHO estimation The business to be worth 20,00 Billion USD world wide Up to 30% of Medicines in Raussia and in some countries in Africa, Asia and Latin america are counterfeit. In wealthy nations the figure is 1%.

High Quality Medicines Efficacy Safety

Imported Medicines Poorly regulated Manufacturing origin is not evaluated The quality records are uncertain Batch analysis can’t properly conducted

Local Manufacturer Certified by the Medical Agency of the country Easy to conduct Inspection and evaluating the systems in accordance to cGMP – Quality system – Facility and equipment system – Material handling and the storage system

Production system measures Packaging and labeling system Laboratory controlling system Distribution system

Regulation of the imported medicines Registration of the manufacturer Limitation of the number of companies importing medicines Limitation of the number of products of the same entity Fight Against Fake Medicines Private and Public

Establish a good supply chain system for the public sector Fight Against Fake Medicines

Manufacturing site Wholesaler Pharmacy Local Manufacturer

Thank you